Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: Audiol Neurootol. 2015 Apr 1;20(3):166–171. doi: 10.1159/000367883

Table 2.

Demographic information for hearing preservation users.

Subj Age Gender Age
HL
onset
(in
years)
Processor/

HA
Years
of CI
Use
CI Ear/
Device
Strategy # Active

Channels/

#
Available
Channels
Frequency
Allocation
in Hz
Etiology
of
Deafness
2 68 M 27 Tempo+Duet/Widex 5 L/MED-EL Pulsar EAS CIS 10/12 500–8500 Unknown
3 67 M 21 Tempo+Duet/Phonak 1 R/ME Sonata EAS Flex CIS 10/12 500–8500 Noise Exposure
4 39 F 14 Tempo+Duet/Tempo+Duet 1 R/ME Pulsar EAS Flex CIS 12/12 300–8500 Unknown
5 79 M 40 Freedom/Phonak 2 R/CA Hybrid L24 ACE 18/24 1188–7938 Hereditary
6 55 F 40 Freedom/Phonak 2 R/CA Hybrid L24 ACE 18/24 1188–7938 Unknown
7 70 M 42 Freedom/Widex 1.6 L/CA Hybrid L24 ACE 18/24 1188–7938 Hereditary
8 64 M 20 Opus 2 Duet/Danalogics 6 L/ME Pulsar Medium FSP 10/12 690–8500 Hereditary
9 69 F 47 Opus 2/Phonak 1 R/ME Sonata Flex FSP 10/12 100–8000 Hereditary
10 47 F 32 Freedom/Phonak 3 R/CA Hybrid L24 ACE 18/24 1188–7938 Unknown
11 35 M 5 Opus 2/Unaided 2 L/ME Sonata Medium FSP 11/12 332–7500 Unknown
12 50 F 32 Freedom/Phonak 3 R/CA Hybrid L24 MP12 20/24 1188–7938 Hereditary
13 62 F 52 Tempo+Duet/Phonak 2 L/ME Sonata EAS Flex CIS 12/12 500–8500 Viral Infection

ME = MED-EL. CC = Cochlear Corp.